107202-52-8 Usage
Uses
Used in Organic Synthesis:
(2S,3S)-N-BOC-3-AMINO)-1,2-EPOXY-5-(ISOPROPYL)BUTANE is used as a key intermediate in organic synthesis for the creation of various complex organic molecules. Its unique structure allows for multiple points of reactivity and functionalization, facilitating the synthesis of a wide range of compounds.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (2S,3S)-N-BOC-3-AMINO)-1,2-EPOXY-5-(ISOPROPYL)BUTANE is utilized as a building block for the design and synthesis of new pharmaceuticals. Its diverse functional groups can be leveraged to create molecules with specific biological activities, potentially leading to the development of novel drugs with improved therapeutic properties.
Used in Pharmaceutical Development:
(2S,3S)-N-BOC-3-AMINO)-1,2-EPOXY-5-(ISOPROPYL)BUTANE is used as a precursor in the synthesis of pharmaceutical compounds. Its unique combination of functional groups allows for the creation of molecules with specific therapeutic targets, contributing to the advancement of drug discovery and development.
Used in Advanced Organic Molecule Design:
In the design of advanced organic molecules, (2S,3S)-N-BOC-3-AMINO)-1,2-EPOXY-5-(ISOPROPYL)BUTANE serves as a versatile component. Its structural features enable the development of molecules with tailored properties for applications in various industries, such as materials science, nanotechnology, and biotechnology.
Check Digit Verification of cas no
The CAS Registry Mumber 107202-52-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,2,0 and 2 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 107202-52:
(8*1)+(7*0)+(6*7)+(5*2)+(4*0)+(3*2)+(2*5)+(1*2)=78
78 % 10 = 8
So 107202-52-8 is a valid CAS Registry Number.
107202-52-8Relevant academic research and scientific papers
OXIME DERIVATIVE HYDROXYETHYLAMINE ASPARTYL-PROTEASE INHIBITORS
-
Page/Page column 126-127, (2010/02/15)
The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
